Delivery Order SPE2DB22D9207-SPE2DB24FH5BF

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,571.60 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR pharmaceutical products. The award is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was issued by the Defense Logistics Agency (DLA) for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. The contract is a firm fixed-price delivery order with a ceiling value of $7,571.60 and an ultimate completion date of October 16, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,785.80 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, with a period of performance through April 19, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,785.80 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm-fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a biologic medication. This award is under the SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, a biologic medication, with a performance period ending on May 22, 2024. This award is under a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,785.80 firm fixed-price delivery order is for NUCALA 100 MG/ML AUTO-INJECTORML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB24FH5BF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,143.20 firm fixed-price delivery order contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR products, with a period of performance through June 6, 2024.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation. Through this vehicle, DMS Pharmaceutical Group provides a wide array of branded, generic, and specialty medications to support the diverse medical requirements of the Department of Defense healthcare system.

Generated 9/4/24, 9:38 AM